These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 26536421)
21. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
22. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model. Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417 [TBL] [Abstract][Full Text] [Related]
23. Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation. Huang CH; Chen WY; Chen RF; Ramachandran S; Liu KF; Kuo YR Asian J Surg; 2024 Oct; 47(10):4251-4259. PubMed ID: 38704267 [TBL] [Abstract][Full Text] [Related]
24. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase. Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596 [TBL] [Abstract][Full Text] [Related]
25. The need for inducing tolerance in vascularized composite allotransplantation. Ravindra KV; Xu H; Bozulic LD; Song DD; Ildstad ST Clin Dev Immunol; 2012; 2012():438078. PubMed ID: 23251216 [TBL] [Abstract][Full Text] [Related]
26. Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments. Leonard DA; McGrouther DA; Kurtz JM; Cetrulo CL Clin Dev Immunol; 2012; 2012():863264. PubMed ID: 23320020 [TBL] [Abstract][Full Text] [Related]
28. Acute rejection in vascularized composite allotransplantation. Fischer S; Lian CG; Kueckelhaus M; Strom TB; Edelman ER; Clark RA; Murphy GF; Chandraker AK; Riella LV; Tullius SG; Pomahac B Curr Opin Organ Transplant; 2014 Dec; 19(6):531-44. PubMed ID: 25333831 [TBL] [Abstract][Full Text] [Related]
29. Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation. Schweizer R; Taddeo A; Waldner M; Klein HJ; Fuchs N; Kamat P; Targosinski S; Barth AA; Drach MC; Gorantla VS; Cinelli P; Plock JA Am J Transplant; 2020 May; 20(5):1272-1284. PubMed ID: 31774619 [TBL] [Abstract][Full Text] [Related]
30. The role of B cell immunity in VCA graft rejection and acceptance. Kaufman CL; Cascalho M; Ozyurekoglu T; Jones CM; Ramirez A; Roberts T; Tien HY; Moreno R; Galvis E; Tsai TM; Palazzo M; Farner S; Platt JL Hum Immunol; 2019 Jun; 80(6):385-392. PubMed ID: 30836129 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model. Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158 [TBL] [Abstract][Full Text] [Related]
33. Immunobiology in VCA. Kaufman CL; Marvin MR; Chilton PM; Hoying JB; Williams SK; Tien H; Ozyurekoglu T; Ouseph R Transpl Int; 2016 Jun; 29(6):644-54. PubMed ID: 26924305 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? Howsare M; Jones CM; Ramirez AM Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463 [TBL] [Abstract][Full Text] [Related]
37. Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation. Plock JA; Schnider JT; Solari MG; Zheng XX; Gorantla VS Front Immunol; 2013; 4():175. PubMed ID: 23888159 [TBL] [Abstract][Full Text] [Related]
38. Current concepts and systematic review of vascularized composite allotransplantation of the abdominal wall. Berli JU; Broyles JM; Lough D; Shridharani SM; Rochlin D; Cooney DS; Lee WP; Brandacher G; Sacks JM Clin Transplant; 2013; 27(6):781-9. PubMed ID: 24102820 [TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of the Reported Complications Related to Facial and Upper Extremity Vascularized Composite Allotransplantation. Milek D; Reed LT; Echternacht SR; Shanmugarajah K; Cetrulo CL; Lellouch AG; Langstein HN; Leckenby JI J Surg Res; 2023 Jan; 281():164-175. PubMed ID: 36162189 [TBL] [Abstract][Full Text] [Related]
40. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants. Chen B; Xu H; Corbin DR; Ildstad ST Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]